Medindia LOGIN REGISTER
Medindia
CKM Syndrome: AHA Includes Kidney Disease in Cardiovascular Risk Factors

CKM Syndrome: AHA Includes Kidney Disease in Cardiovascular Risk Factors

Listen to this article
0:00/0:00

The Cardiovascular-Kidney-Metabolic (CKM) syndrome emphasizes the connections between obesity, Type 2 diabetes, kidney disease, and cardiovascular disease.

Highlights:
  • The American Heart Association (AHA) has proposed a groundbreaking shift by adding kidney disease as a risk factor for Cardiovascular Disease (CVD)
  • This new approach, termed the CKM syndrome, highlights the interconnection between cardiovascular disease, kidney disease, Type 2 diabetes, and obesity
  • The AHA's advisory underscores the importance of early intervention, a unified healthcare approach to manage CKM syndrome and improve patient care
The American Heart Association (AHA) has made a groundbreaking proposal by including Kidney disease as a risk factor for Cardiovascular Disease (CVD).
In a presidential advisory published in the journal Circulation, the AHA introduces the concept of the cardiovascular-kidney-metabolic (CKM) syndrome, highlighting the interconnectedness of conditions such as cardiovascular disease, kidney disease, Type 2 diabetes, and obesity.

Understanding the Cardiovascular-Kidney-Metabolic Syndrome

CKM syndrome, as defined by the AHA, affects multiple organs in the body, including the heart, brain, kidney, and liver.

Its primary impact, however, is on the cardiovascular system, influencing various aspects like blood vessels, heart muscle function, arterial fatty buildup, and cardiac electrical impulses. The advisory underscores the importance of identifying individuals in the early stages of CKM syndrome (1 Trusted Source
Report redefines overlapping risks of heart and kidney diseases

Go to source
).

With CKM syndrome's emergence tied to the high prevalence of obesity and Type 2 diabetes, the AHA advisory recognizes that these metabolic conditions contribute significantly to cardiovascular disease risk.

Notably, cardiovascular disease is the leading cause of death for individuals with both Type 2 diabetes and chronic kidney disease.

Early Intervention and Comprehensive Care- Key to Manage CKM Syndrome

The advisory also emphasizes the availability of therapies that can prevent the progression of kidney and heart diseases. By screening for kidney and metabolic conditions early, healthcare professionals can initiate protective measures to prevent heart disease and manage existing cardiac conditions more effectively.

CKM syndrome management can be complex due to the involvement of multiple conditions. Fragmented care can be a challenge, especially for individuals facing barriers to healthcare access. The AHA advisory encourages healthcare professionals from various specialties to work collaboratively in a unified approach to treat the whole patient.

Furthermore, the advisory underscores the significance of systematically screening for and addressing social factors that influence health. These determinants, such as nutrition security and opportunities for physical activity, are essential aspects of optimal CKM syndrome care.

Advertisement
The AHA's visionary move recognizes the intricate web of cardiovascular, kidney, and metabolic health and aims to improve preventive healthcare strategies for those at risk or affected by CKM syndrome.

This redefined perspective promises to enhance the management and well-being of individuals facing these interrelated health challenges.

Advertisement
Reference:
  1. Report redefines overlapping risks of heart and kidney diseases - (https://www.heart.org/en/news/2023/10/09/report-redefines-overlapping-risks-of-heart-and-kidney-diseases)


Source-Medindia


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education